Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €17.48 EUR
Change Today -0.275 / -1.55%
Volume 0.0
MM3 On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 9:31 AM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

merit medical systems inc (MM3) Snapshot

Open
€17.48
Previous Close
€17.75
Day High
€17.48
Day Low
€17.48
52 Week High
03/17/15 - €18.26
52 Week Low
07/30/14 - €8.82
Market Cap
768.2M
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
44.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MERIT MEDICAL SYSTEMS INC (MM3)

Related News

No related news articles were found.

merit medical systems inc (MM3) Related Businessweek News

No Related Businessweek News Found

merit medical systems inc (MM3) Details

Merit Medical Systems, Inc. designs, develops, manufactures, and markets medical devices for interventional and diagnostic procedures worldwide. The company’s Cardiovascular segment offers cardiology and radiology devices for diagnosing and treating coronary arterial, peripheral vascular, and other non-vascular diseases; and embolotherapeutic products. It offers vascular access products and accessories; safety and waste management systems; hemostasis management devices; guide wires and accessories; diagnostic catheters; hemostasis valves; inflation devices; drainage catheters and accessories; paracentesis, thoracentesis, and pericardiocentesis catheters; thrombosis products; multipurpose microcatheters; embolic particles and products; vascular retrieval devices; angiography and angioplasty accessories; hemodialysis and peritoneal dialysis; and cardiac rhythm management and electrophysiology devices. The company’s Endoscopy segment provides gastroenterology and pulmonology medical devices for expanding esophageal, tracheobronchial, and biliary strictures caused by malignant tumors. It offers airway, esophageal, and biliary stents; stent sizing devices; guide wires; bipolar coagulation probes; inflation devices; cholangiography rapid refill continuous injection kits; oropharyngeal airway, bite block, and oxygen administration devices; and bronchoalveolar lavage convenience kits. The company also provides support catheters, discography products, coated wires and tubes, and pressure sensors. It serves hospitals and clinic-based cardiologists, radiologists, neurologists, nephrologists, vascular surgeons, interventional gastroenterologists and pulmonologists, thoracic surgeons, physiatrists, nephrologists, vascular surgeons, oncologists, electrophysiologists, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, and tray manufacturers. The company was founded in 1987 and is headquartered in South Jordan, Utah.

3,105 Employees
Last Reported Date: 03/5/15
Founded in 1987

merit medical systems inc (MM3) Top Compensated Officers

Chairman of The Board, Chief Executive Office...
Total Annual Compensation: $1.1M
Chief Financial Officer, Treasurer, Secretary...
Total Annual Compensation: $403.7K
Chief Operating Officer
Total Annual Compensation: $317.5K
Chief Legal Officer
Total Annual Compensation: $400.7K
Executive Officer
Total Annual Compensation: $325.0K
Compensation as of Fiscal Year 2014.

merit medical systems inc (MM3) Key Developments

Merit Medical Systems, Inc. Proposes Amendments to Charter

Merit Medical Systems, Inc. proposed to vote upon a shareholder proposal to request that the board of directors initiate the appropriate process to amend the company's charter documents to require a majority vote in uncontested elections of directors of the company to its upcoming annual general meeting going to be held on May 21, 2015.

Merit Medical Systems, Inc. Presents at Sidoti 19th Annual Small-Cap Equity Conference, Mar-16-2015 09:20 AM

Merit Medical Systems, Inc. Presents at Sidoti 19th Annual Small-Cap Equity Conference, Mar-16-2015 09:20 AM. Venue: The Grand Hyatt Hotel, New York City, New York, United States. Speakers: Fred P. Lampropoulos, Chairman of The Board, Chief Executive Officer and President.

Merit Medical Systems, Inc. Announces Earnings Results for the Full Year Ended December 31, 2014; Provides Earnings Guidance for the Years of 2015, 2016 and 2017

Merit Medical Systems, Inc. announced earnings results for the full year ended December 31, 2014. For the year, the company reported free cash flow was $19 million. EBITDA was $78.1 million. Non-GAAP earnings per share were $0.78. For the year 2015, the company expected sales in the range of $535 million to $545 million. Gross margin is expected to be in the range of 46.5% to 47.5%. Income from operations is expected to be in the range of 10.9% to 11.9%. Non-GAAP earnings per share are expected to be in the range of $0.85 to $0.89. EBITDA is expected to be in the range of $84 million to $88 million. Free cash flow is expected to be in the range of $20 million to $25 million. For the year 2016, the company expected sales in the range of $580 million to $590 million. Gross margin is expected to be in the range of 47.0% to 48.0%. Income from operations is expected to be in the range of 11.5% to 12.5%. Non-GAAP earnings per share are expected to be in the range of $0.95 to $1.01. EBITDA is expected to be in the range of $90 million to $96 million. Free cash flow is expected to be in the range of $30 million to $35 million. For the year 2017, the company expected sales in the range of $625 million to $635 million. Gross margin is expected to be in the range of 47.8% to 48.8%. Income from operations is expected to be in the range of 12.4% to 13.4%. Non-GAAP earnings per share are expected to be in the range of $1.10 to $1.18. EBITDA is expected to be in the range of $98 million to $106 million. Free cash flow is expected to be in the range of $35 million to $40 million.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MM3:GR €17.48 EUR -0.275

MM3 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AngioDynamics Inc $16.60 USD -0.25
Greatbatch Inc $53.95 USD -0.80
Masimo Corp $34.14 USD -0.32
NxStage Medical Inc $18.20 USD -0.10
Orthofix International NV $36.58 USD -0.74
View Industry Companies
 

Industry Analysis

MM3

Industry Average

Valuation MM3 Industry Range
Price/Earnings 36.1x
Price/Sales 1.6x
Price/Book 1.9x
Price/Cash Flow 36.5x
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERIT MEDICAL SYSTEMS INC, please visit www.merit.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.